Archives

by in
Entry Author Date Location
Dendreon CEO John Johnson: ‘This is My Last Stop’ 04/17/12 Seattle
OncoGenex Snags $50M for Prostate Cancer Drug Plan 03/16/12 Seattle
OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up 03/08/12 Seattle
J&J Prostate Cancer Drug Hits Goal; Hurts Dendreon, Helps Medivation 03/08/12 New York
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation 01/27/12 Seattle
Medivation Fails Alzheimer’s Trial, Pfizer Drops Out of Partnership 01/17/12 San Francisco
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
Medivation, Astellas Prostate Cancer Drug Helps Men Live Longer; Shares Skyrocket 11/03/11 San Francisco
Tokai Snaps Up $23M From Novartis and Apple Tree to Challenge Leaders in Prostate Cancer 09/20/11 Boston
Medivation Flunks Huntington’s Trial, Calibra Nabs Venture Cash, Open Source Biology Comes to SF, & More Bay Area Life Sciences News 04/15/11 San Francisco
Medivation, Pfizer Fail Huntington’s Test 04/11/11 San Francisco
Allon Treads Into the Great Unknown, Alzheimer’s Disease, With New Kind of Drug 04/06/10 Seattle
OncoGenex Grabs $60M Upfront From Teva for Rights to Cancer Drug, Shares Drop Anyway 12/21/09 Seattle
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer 11/10/09 Boston
How to Tap Russia for Biomedical Breakthroughs: Lessons from Boston BioCom 10/15/09 Boston
Stopping Alzheimer’s Cold: Satori Raises $22M to Pursue Its Vision 01/08/09 Boston
Prostate Cancer Drug Vaults OncoGenex Onto Investor Radar Screens 12/16/08 Seattle
Epix Unveiling Full Alzheimer’s Results at Medical Meeting, No More Surprises 07/22/08 Boston
Page 2 of 2 « previous page